Table 3.
Results on primary outcomes pre- and post-intervention.
| Experimental Group (n = 8) |
Control Group (n = 6) |
MANOVA (2 × 2) |
|||||
|---|---|---|---|---|---|---|---|
| Pre-Test | Post-Test | % Change | Pre-Test | Post-Test | % Change | ||
| Mean ± sd | Mean ± sd | Mean ± sd | Mean ± sd | ||||
| PDQ-39 Score Total | 20.66 ± 8.76 | 21.47 ± 10.50 | −3.92 | 12.05 ± 7.74 | 10.96 ± 7.33 | 9.05 | F1,23 = 0.120; p = 0.732 |
| MDS-UPDRS III | 20.05 ± 13.64 | 19.55 ± 27.34 | 2.50 | 12.36 ± 8.37 | 7.31 ± 5.16 | 59.14 | F1,23 = 2.062; p = 0.045 * |
| MDS-UPDRS Score Total | 18.53 ± 9.46 | 9.42 ± 10.40 | 50.38 | 10.43 ± 8.36 | 3.77 ± 2.69 | 64.95 | F1,23 = 0.002; p = 0.962 |
| TUG Total Time (s) | 12.53 ± 3.28 | 11.31 ± 6.06 | 9.74 | 10.49 ± 5.63 | 8.96 ± 3.37 | 58.59 | F1,23 = 0.004; p = 0.949 |
| TUG Animals Total Time (s) | 14.22 ± 4.08 | 17.09 ± 9.93 | −20.18 | 12.32 ± 5.76 | 10.76 ± 3.87 | 12.66 | F1,23 = 0.004; p = 0.950 |
| TUG Numbers Total Time (s) | 14.49 ± 3.03 | 14.77 ± 6.73 | −1.93 | 12.38 ± 5.37 | 11.51 ± 3.72 | 7.03 | F1,23 = 0.005; p = 0.943 |
| 30 Second Chair Stand Test | 11.50 ± 3.25 | 13.50 ± 3.16 | 17.39 | 14.14 ± 2.61 | 14.67 ± 3.67 | 3.75 | F1,23 = 0.691; p = 0.415 |
Obs. PDQ, Parkinson´s disease quality of life questionnaire; MDS-UPDRS, Movement Disorder Society´s Unified Parkinson´s Disease Rating Scale; TUG, Timed Up and Go Test; * p < 0.05.